These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11511364)

  • 1. Myc requires distinct E2F activities to induce S phase and apoptosis.
    Leone G; Sears R; Huang E; Rempel R; Nuckolls F; Park CH; Giangrande P; Wu L; Saavedra HI; Field SJ; Thompson MA; Yang H; Fujiwara Y; Greenberg ME; Orkin S; Smith C; Nevins JR
    Mol Cell; 2001 Jul; 8(1):105-13. PubMed ID: 11511364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
    Ebelt H; Hufnagel N; Neuhaus P; Neuhaus H; Gajawada P; Simm A; Müller-Werdan U; Werdan K; Braun T
    Circ Res; 2005 Mar; 96(5):509-17. PubMed ID: 15718499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1 is crucial for E2F-dependent apoptosis.
    Lazzerini Denchi E; Helin K
    EMBO Rep; 2005 Jul; 6(7):661-8. PubMed ID: 15976820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis.
    Rempel RE; Mori S; Gasparetto M; Glozak MA; Andrechek ER; Adler SB; Laakso NM; Lagoo AS; Storms R; Smith C; Nevins JR
    PLoS Genet; 2009 Sep; 5(9):e1000640. PubMed ID: 19749980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.
    Vigo E; Müller H; Prosperini E; Hateboer G; Cartwright P; Moroni MC; Helin K
    Mol Cell Biol; 1999 Sep; 19(9):6379-95. PubMed ID: 10454584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.
    Novy M; Pohn R; Andorfer P; Novy-Weiland T; Galos B; Schwarzmayr L; Rotheneder H
    Mol Biol Cell; 2005 May; 16(5):2181-90. PubMed ID: 15716352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
    Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
    Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of E2F1 by BRCT domain-containing protein TopBP1.
    Liu K; Lin FT; Ruppert JM; Lin WC
    Mol Cell Biol; 2003 May; 23(9):3287-304. PubMed ID: 12697828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles for E2F proteins in cell growth control and apoptosis.
    DeGregori J; Leone G; Miron A; Jakoi L; Nevins JR
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7245-50. PubMed ID: 9207076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 and c-Myc in cell growth and death.
    Matsumura I; Tanaka H; Kanakura Y
    Cell Cycle; 2003; 2(4):333-8. PubMed ID: 12851485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
    Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
    Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ; Dicker AJ; Dahler AL; Saunders NA
    J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E2F1-3 transcription factors are essential for cellular proliferation.
    Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G
    Nature; 2001 Nov; 414(6862):457-62. PubMed ID: 11719808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q; Hung FC; Fromm L; Overbeek PA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARF differentially modulates apoptosis induced by E2F1 and Myc.
    Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
    Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
    Elliott MJ; Dong YB; Yang H; McMasters KM
    Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the G1/S transition phase in mesangial cells by E2F1.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.